Science at Sanofi
Events
Stay up to date and register for the latest events and view webinar recordings
European Academy of Allergy and Clinical Immunology (EAACI) Congress Highlights
13–16 June 2025, in Glasgow, Scotland.
Cutting-Edge Science
Discover medical insights and trends from trusted sources and key opinion leaders.
Updated Evidence from the EVEREST Phase 4 Trial
First, prospective, head-to-head data comparing Dupilumab and Omalizumab in CRSwNP and asthma patients.
Management of Hypertension in Diabetic Nephropathy Patients - Dr. SP Chan
Join Dr. S. P. Chan, Consultant Endocrinologist, as she discusses key principles in managing hypertension in patients with diabetes, with a special focus on diabetic nephropathy.
In this video, Dr. Chan answers frequently asked questions and shares practical insights to help healthcare professionals optimize care and protect kidney health in diabetic patients.
Personalizing Cardiovascular Care in Asian Populations: Insights on Antiplatelet Safety & Lipid Risk
Beyfortus®: Made with All Infants in Mind to Protect Against RSV
Up to 75% of RSV-associated hospitalisations occur in healthy and full-term children.2 Recent studies have shown that nirsevimab provided up to 90% protection against hospitalisation from severe RSV LRTI in infants during their first RSV season.3
Understanding RSV: Disease Burden and Nirsevimab’s Efficacy
In Singapore, RSV circulates all-year round and causes significant paediatric health and economic burden.2 This highlights the need and importance of RSV immunisation to reduce the burden of disease.2
Request-form
